3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

Clinical trial NCT05245292 · COMPLETED

Trial details

NCT number: NCT05245292
Sponsor: Rockefeller University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus

Start date: 2022-12-07
Primary completion: 2025-12-09
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.